1
TITLE: Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT (Nature Communications, (2017), 8, 1, (14687), 10.1038/ncomms14687)
AUTHORS: Richard Hill; Patricia Madureira; Bibiana Ferreira; Inês Baptista; Susana Machado; Laura Colaҫo; Marta dos Santos; Ningshu Liu; Ana Dopazo; Selma Ugurel; Angyal Adrienn; Endre Kiss Toth; Murat Isbilen; Ali Gure; Wolfgang Link;
PUBLISHED: 2023, SOURCE: Nature Communications, VOLUME: 14, ISSUE: 1
INDEXED IN: Scopus
2
TITLE: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT (Retraction of Vol 8, art no 14687, 2017)
AUTHORS: Hill, Richard; Madureira, Patricia A. A.; Ferreira, Bibiana; Baptista, Ines; Machado, Susana; Colaco, Laura; dos Santos, Marta; Liu, Ningshu; Dopazo, Ana; Ugurel, Selma; Adrienn, Angyal; Kiss Toth, Endre; Isbilen, Murat; Gure, Ali O. O.; Link, Wolfgang;
PUBLISHED: 2023, SOURCE: NATURE COMMUNICATIONS, VOLUME: 14, ISSUE: 1
INDEXED IN: WOS
4
TITLE: The role of hypoxia in glioblastoma radiotherapy resistance
AUTHORS: Chédeville, AL; Madureira, PA;
PUBLISHED: 2021, SOURCE: Cancers, VOLUME: 13, ISSUE: 3
INDEXED IN: Scopus CrossRef: 55
IN MY: ORCID
5
TITLE: Investigating glioblastoma response to hypoxia
AUTHORS: Chédeville, AL; Lourdusamy, A; Monteiro, AR; Hill, R; Madureira, PA;
PUBLISHED: 2020, SOURCE: Biomedicines, VOLUME: 8, ISSUE: 9
INDEXED IN: Scopus CrossRef: 31
IN MY: ORCID
6
TITLE: Annexin A2 Regulates AKT Upon H2O2-Dependent Signaling Activation in Cancer Cells
AUTHORS: Castaldo, SA; Ajime, T; Serrao, G; Anastacio, F; Rosa, JT; Giacomantonio, CA; Howarth, A; Hill, R; Madureira, PA;
PUBLISHED: 2019, SOURCE: CANCERS, VOLUME: 11, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 29
IN MY: ORCID
7
TITLE: Modulating autophagy as a therapeutic strategy for the treatment of paediatric high-grade glioma
AUTHORS: Howarth, A; Madureira, PA; Lockwood, G; Storer, LCD; Grundy, R; Rahman, R; Pilkington, GJ; Hill, R;
PUBLISHED: 2019, SOURCE: BRAIN PATHOLOGY, VOLUME: 29, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID
8
TITLE: IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas
AUTHORS: Mihajluk, K; Simms, C; Reay, M; Madureira, PA; Howarth, A; Murray, P; Nasser, S; Duckworth, CA; Pritchard, DM; Pilkington, GJ; Hill, R;
PUBLISHED: 2019, SOURCE: CANCER LETTERS, VOLUME: 458
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
9
TITLE: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
AUTHORS: Hill, R; Madureira, PA; Ferreira, B; Baptista, I; Machado, S; Colaco, L; dos Santos, M; Liu, NS; Dopazo, A; Ugurel, S; Adrienn, A; Kiss Toth, E; Isbilen, M; Gure, AO; Link, W;
PUBLISHED: 2017, SOURCE: NATURE COMMUNICATIONS, VOLUME: 8, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 65
IN MY: ORCID
10
TITLE: Mechanism of plasmin generation by S100A10
AUTHORS: Miller, VA; Madureira, PA; Kamaludin, AA; Komar, J; Sharma, V; Sahni, G; Thewell, C; Longstaff, C; Waisman, DM;
PUBLISHED: 2017, SOURCE: THROMBOSIS AND HAEMOSTASIS, VOLUME: 117, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 20
IN MY: ORCID
Page 1 of 3. Total results: 29.